Blog

Principal Investigator Of Suspended Cytori Stem Cell Trials Remains Hopeful – Forbes

Principal Investigator Of Suspended Cytori Stem Cell Trials Remains Hopeful
Forbes
Shares of Cytori Therapeutics took a big bit hit today after the company disclosed in a press release that it had suspended enrollment in its ATHENA and ATHENA II trials. This kind of news is never a good sign, but the principal investigator of the …
Cytori shares slammed as safety concerns halt stem cell trialsFierceBiotech


Cytori halts stem cell study due to adverse eventsSan Diego Source (subscription)

all 31 news articles »

2014-08-06 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.